Malaysia secures 12.8 mln doses of Pfizer vaccine, delivery from Q1

Reuters2020-11-27

KUALA LUMPUR, Nov 27 (Reuters) - Malaysia is expected to receive its first COVID-19 vaccines from Pfizer in the first quarter of 2021 after signing a deal for 12.8 million doses from the U.S. manufacturer, Prime Minister Muhyiddin Yassin said on Friday.

The deal is expected to cover 6.4 million Malaysians, or 20 percent of the population, with another 10 percent to be covered under Malaysia's participation in the global COVAX facility, backed by the World Health Organization.

Pfizer has agreed to deliver the first one million doses in the first quarter of 2021, with 1.7 million doses, 5.8 million and 4.3 million to follow in subsequent quarters, Muhyiddin said.

The vaccination programme would prioritise "high-risk groups... including frontliners, senior citizens, and those with non-communicable diseases, such as heart diseases, diabetes," he said during a televised news conference.

The Pfizer vaccine still requires approvals from regulator including the U.S. Food and Drug Administration and Malaysia's Health Ministry before it can be distributed, Muhyiddin said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
3